Celon Pharma SA (CLNP)

Warsaw
Currency in PLN
26.70
+0.30(+1.14%)
Closed
CLNP Scorecard
Full Analysis
Net income is expected to grow this year
Fair Value
Day's Range
25.8527.20
52 wk Range
14.6432.90
Key Statistics
Edit
Bid/Ask
26.70 / 26.75
Prev. Close
26.4
Open
26.5
Day's Range
25.85-27.2
52 wk Range
14.64-32.9
Volume
24.39K
Average Volume (3m)
40.8K
1-Year Change
72.26%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CLNP Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
27.64
Upside
+3.52%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

Celon Pharma SA Company Profile

Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. operates as a subsidiary of Glatton Sp. z o.o.

Employees
562
Market
Poland

Compare CLNP to Peers and Sector

Metrics to compare
CLNP
Peers
Sector
Relationship
P/E Ratio
77.7x15.7x−0.5x
PEG Ratio
0.460.270.00
Price/Book
2.8x2.5x2.6x
Price / LTM Sales
6.9x2.5x3.0x
Upside (Analyst Target)
4.9%46.2%56.3%
Fair Value Upside
Unlock27.5%10.0%Unlock

Analyst Ratings

2 Buy
2 Hold
1 Sell
Ratings:
5 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 27.64
(+3.52% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.349
Dividend Yield
0.30%
Industry Median 0.95%
Annualized payout
0.08
Paid annually
5-Years Growth
-19.73%
Growth Streak

Earnings

Latest Release
Nov 20, 2024
EPS / Forecast
-- / --
Revenue / Forecast
120.00M / 57.80M
EPS Revisions
Last 90 days

People Also Watch

211.00
SNTP
+1.93%
17.30
PCOP
+1.47%
639.00
BDXP
+0.63%
8.90
OPL
+1.60%
14.280
MRB
+0.56%

FAQ

What Is the Celon Pharma (CLNP) Stock Price Today?

The Celon Pharma stock price today is 26.70

What Stock Exchange Does Celon Pharma Trade On?

Celon Pharma is listed and trades on the Warsaw stock exchange.

What Is the Stock Symbol for Celon Pharma?

The stock symbol for Celon Pharma is "CLNP."

Does Celon Pharma Pay Dividends? What’s The Current Dividend Yield?

The Celon Pharma dividend yield is 0.30%.

What Is the Celon Pharma Market Cap?

As of today, Celon Pharma market cap is 1.44B.

What is Celon Pharma Earnings Per Share?

The Celon Pharma EPS is 0.349.

What Is the Next Celon Pharma Earnings Date?

Celon Pharma will release its next earnings report on Apr 23, 2025.

From a Technical Analysis Perspective, Is CLNP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.